Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer ...

The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

NEW YORK (AP) — The Trump administration will require all 50 states to explain their plans to revalidate some of their ...

The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...

The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...

Dr. Mehmet Oz announced an initiative, requiring all 50 states to audit their Medicaid provider networks in a move marking a ...